Table of Contents
International Journal of Molecular Imaging
Volume 2011, Article ID 543267, 12 pages
http://dx.doi.org/10.1155/2011/543267
Review Article

SPECT Imaging Agents for Detecting Cerebral β-Amyloid Plaques

Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan

Received 29 July 2010; Revised 6 November 2010; Accepted 24 January 2011

Academic Editor: Alexander Drzezga

Copyright © 2011 Masahiro Ono and Hideo Saji. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. J. Selkoe, “Alzheimer's disease: genes, proteins, and therapy,” Physiological Reviews, vol. 81, no. 2, pp. 741–766, 2001. View at Google Scholar · View at Scopus
  2. J. A. Hardy and G. A. Higgins, “Alzheimer's disease: the amyloid cascade hypothesis,” Science, vol. 256, no. 5054, pp. 184–185, 1992. View at Google Scholar · View at Scopus
  3. C. A. Mathis, Y. Wang, and W. E. Klunk, “Imaging β-amyloid plaques and neurofibrillary tangles in the aging human brain,” Current Pharmaceutical Design, vol. 10, no. 13, pp. 1469–1492, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Nordberg, “PET imaging of amyloid in Alzheimer's disease,” Lancet Neurology, vol. 3, no. 9, pp. 519–527, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Ono, “Development of positron-emission tomography/single-photon emission computed tomography imaging probes for in vivo detection of β-amyloid plaques in Alzheimer's brains,” Chemical and Pharmaceutical Bulletin, vol. 57, no. 10, pp. 1029–1039, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. N. P. L. G. Verhoeff, A. A. Wilson, S. Takeshita et al., “In-vivo imaging of Alzheimer disease β-amyloid with [C11]SB-13 PET,” American Journal of Geriatric Psychiatry, vol. 12, no. 6, pp. 584–595, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. H. F. Kung, S. R. Choi, W. Qu, W. Zhang, and D. Skovronsky, “F18 stilbenes and styrylpyridines for PET imaging of Aβ plaques in Alzheimer's disease: a miniperspective,” Journal of Medicinal Chemistry, vol. 53, no. 3, pp. 933–941, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. C. A. Mathis, Y. Wang, D. P. Holt, G. F. Huang, M. L. Debnath, and W. E. Klunk, “Synthesis and evaluation of C11-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents,” Journal of Medicinal Chemistry, vol. 46, no. 13, pp. 2740–2754, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. W. E. Klunk, H. Engler, A. Nordberg et al., “Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B,” Annals of Neurology, vol. 55, no. 3, pp. 306–319, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. N. M. Scheinin, S. Aalto, J. Koikkalainen et al., “Follow-up of [C11]PIB uptake and brain volume in patients with alzheimer disease and controls,” Neurology, vol. 73, no. 15, pp. 1186–1192, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Ono, A. Wilson, J. Nobrega et al., “C11-labeled stilbene derivatives as Aβ-aggregate-specific PET imaging agents for Alzheimer's disease,” Nuclear Medicine and Biology, vol. 30, no. 6, pp. 565–571, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Kudo, N. Okamura, S. Furumoto et al., “2-(2-[2-dimethylaminothiazol-5-yl]ethenyl)-6-(2-[fluoro]ethoxy)benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients,” Journal of Nuclear Medicine, vol. 48, no. 4, pp. 553–561, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. A. E. Johnson, F. Jeppsson, J. Sandell et al., “AZD2184: a radioligand for sensitive detection of β-amyloid deposits,” Journal of Neurochemistry, vol. 108, no. 5, pp. 1177–1186, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. E. D. Agdeppa, V. Kepe, J. Liu et al., “Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease,” The Journal of Neuroscience, vol. 21, no. 24, p. RC189, 2001. View at Google Scholar · View at Scopus
  15. K. Shoghi-Jadid, G. W. Small, E. D. Agdeppa et al., “Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with alzheimer disease,” American Journal of Geriatric Psychiatry, vol. 10, no. 1, pp. 24–35, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. G. W. Small, V. Kepe, L. M. Ercoli et al., “PET of brain amyloid and tau in mild cognitive impairment,” New England Journal of Medicine, vol. 355, no. 25, pp. 2652–2663, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. W. Zhang, S. Oya, M. P. Kung, C. Hou, D. L. Maier, and H. F. Kung, “F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Aβ aggregates in the brain,” Nuclear Medicine and Biology, vol. 32, no. 8, pp. 799–809, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. C. C. Rowe, U. Ackerman, W. Browne et al., “Imaging of amyloid β in Alzheimer's disease with F18-BAY94-9172, a novel PET tracer: proof of mechanism,” The Lancet Neurology, vol. 7, no. 2, pp. 129–135, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Zhang, M. P. Kung, S. Oya, C. Hou, and H. F. Kung, “F18-labeled styrylpyridines as PET agents for amyloid plaque imaging,” Nuclear Medicine and Biology, vol. 34, no. 1, pp. 89–97, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. S. R. Choi, G. Golding, Z. Zhuang et al., “Preclinical properties of F-AV-45: a PET agent for Aβ plaques in the brain,” Journal of Nuclear Medicine, vol. 50, no. 11, pp. 1887–1894, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. D. F. Wong, P. B. Rosenberg, Y. Zhou et al., “In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand F18-AV-45 (flobetapir F 18),” Journal of Nuclear Medicine, vol. 51, no. 6, pp. 913–920, 2010. View at Google Scholar · View at Scopus
  22. M. Koole, D. M. Lewis, C. Buckley et al., “Whole-body biodistribution and radiation dosimetry of F18-GE067: a radioligand for in vivo brain amyloid imaging,” Journal of Nuclear Medicine, vol. 50, no. 5, pp. 818–822, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Ono, M. Haratake, M. Nakayama et al., “Synthesis and biological evaluation of (E)-3-styrylpyridine derivatives as amyloid imaging agents for Alzheimer's disease,” Nuclear Medicine and Biology, vol. 32, no. 4, pp. 329–335, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. W. Qu, M. P. Kung, C. Hou, T. E. Benedum, and H. F. Kung, “Novel styrylpyridines as probes for SPECT imaging of amyloid plaques,” Journal of Medicinal Chemistry, vol. 50, no. 9, pp. 2157–2165, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Qu, M. P. Kung, C. Hou, L. W. Jin, and H. F. Kung, “Radioiodinated aza-diphenylacetylenes as potential SPECT imaging agents for β-amyloid plaque detection,” Bioorganic and Medicinal Chemistry Letters, vol. 17, no. 13, pp. 3581–3584, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. M. P. Kung, C. Hou, Z. P. Zhuang et al., “IMPY: an improved thioflavin-T derivative for in vivo labeling of β-amyloid plaques,” Brain Research, vol. 956, no. 2, pp. 202–210, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. Z. P. Zhuang, M. P. Kung, A. Wilson et al., “Structure-activity relationship of imidazo[1,2-a]pyridines as ligands for detecting β-amyloid plaques in the brain,” Journal of Medicinal Chemistry, vol. 46, no. 2, pp. 237–243, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. M. P. Kung, C. Hou, Z. P. Zhuang, D. Skovronsky, and H. F. Kung, “Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease,” Brain Research, vol. 1025, no. 1-2, pp. 98–105, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. Z. P. Zhuang, M. P. Kung, C. Hou et al., “Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates,” Journal of Medicinal Chemistry, vol. 44, no. 12, pp. 1905–1914, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. Z. P. Zhuang, M. P. Kung, C. Hou et al., “IBOX(2-(4′-dimethylaminophenyl)-6-iodobenzoxazole): a ligand for imaging amyloid plaques in the brain,” Nuclear Medicine and Biology, vol. 28, no. 8, pp. 887–894, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Ono, M. P. Kung, C. Hou, and H. F. Kung, “Benzofuran derivatives as Aβ-aggregate-specific imaging agents for Alzheimer's disease,” Nuclear Medicine and Biology, vol. 29, no. 6, pp. 633–642, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Watanabe, M. Ono, M. Haratake, N. Kobashi, H. Saji, and M. Nakayama, “Synthesis and characterization of novel phenylindoles as potential probes for imaging of β-amyloid plaques in the brain,” Bioorganic and Medicinal Chemistry, vol. 18, no. 13, pp. 4740–4746, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. M. P. Kung, C. Hou, Z. P. Zhuang, A. J. Cross, D. L. Maier, and H. F. Kung, “Characterization of IMPY as a potential imaging agent for β-amyloid plaques in double transgenic PSAPP mice,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 31, no. 8, pp. 1136–1145, 2004. View at Google Scholar · View at Scopus
  34. A. B. Newberg, N. A. Wintering, C. M. Clark et al., “Use of I123 IMPY SPECT to differentiate Alzheimer's disease from controls,” The Journal of Nuclear Medicine, vol. 47, supplement 1, p. 78P, 2006. View at Google Scholar
  35. A. B. Newberg, N. A. Wintering, K. Plössl et al., “Safety, biodistribution, and dosimetry of I123-IMPY: a novel amyloid plaque-imaging agent for the diagnosis of Alzheimer's disease,” Journal of Nuclear Medicine, vol. 47, no. 5, pp. 748–754, 2006. View at Google Scholar · View at Scopus
  36. K. Ono, Y. Yoshiike, A. Takashima, K. Hasegawa, H. Naiki, and M. Yamada, “Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease,” Journal of Neurochemistry, vol. 87, no. 1, pp. 172–181, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Ono, N. Yoshida, K. Ishibashi et al., “Radioiodinated flavones for in vivo imaging of β-amyloid plaques in the brain,” Journal of Medicinal Chemistry, vol. 48, no. 23, pp. 7253–7260, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Iwatsubo, A. Odaka, N. Suzuki, H. Mizusawa, N. Nukina, and Y. Ihara, “Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43),” Neuron, vol. 13, no. 1, pp. 45–53, 1994. View at Publisher · View at Google Scholar · View at Scopus
  39. J. C. Morris, M. Storandt, D. W. McKeel et al., “Cerebral amyloid deposition and diffuse plaques in "normal" aging: evidence for presymptomatic and very mild Alzheimer's disease,” Neurology, vol. 46, no. 3, pp. 707–719, 1996. View at Google Scholar · View at Scopus
  40. H. F. Kung, C. W. Lee, Z. P. Zhuang, M. P. Kung, C. Hou, and K. Plössl, “Novel stilbenes as probes for amyloid plaques,” Journal of the American Chemical Society, vol. 123, no. 50, pp. 12740–12741, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Ono, M. Haratake, H. Mori, and M. Nakayama, “Novel chalcones as probes for in vivo imaging of β-amyloid plaques in Alzheimer's brains,” Bioorganic and Medicinal Chemistry, vol. 15, no. 21, pp. 6802–6809, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Ono, M. Hori, M. Haratake, T. Tomiyama, H. Mori, and M. Nakayama, “Structure-activity relationship of chalcones and related derivatives as ligands for detecting of β-amyloid plaques in the brain,” Bioorganic and Medicinal Chemistry, vol. 15, no. 19, pp. 6388–6396, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Ono, M. Haratake, H. Mori, and M. Nakayama, “Novel chalcones as probes for in vivo imaging of β-amyloid plaques in Alzheimer's brains,” Bioorganic and Medicinal Chemistry, vol. 15, no. 21, pp. 6802–6809, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Ono, Y. Maya, M. Haratake, K. Ito, H. Mori, and M. Nakayama, “Aurones serve as probes of β-amyloid plaques in Alzheimer's disease,” Biochemical and Biophysical Research Communications, vol. 361, no. 1, pp. 116–121, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. Y. Maya, M. Ono, H. Watanabe, M. Haratake, H. Saji, and M. Nakayama, “Novel radioiodinated aurones as probes for SPECT imaging of β-amyloid plaques in the brain,” Bioconjugate Chemistry, vol. 20, no. 1, pp. 95–101, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. W. Qu, M. P. Kung, C. Hou, S. Oya, and H. F. Kung, “Quick assembly of 1,4-diphenyltriazoles as probes targeting β-amyloid aggregates in Alzheimer's disease,” Journal of Medicinal Chemistry, vol. 50, no. 14, pp. 3380–3387, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. R. Chandra, M. P. Kung, and H. F. Kung, “Design, synthesis, and structure-activity relationship of novel thiophene derivatives for β-amyloid plaque imaging,” Bioorganic and Medicinal Chemistry Letters, vol. 16, no. 5, pp. 1350–1352, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Ono, M. Haratake, H. Saji, and M. Nakayama, “Development of novel β-amyloid probes based on 3,5-diphenyl-1,2,4-oxadiazole,” Bioorganic and Medicinal Chemistry, vol. 16, no. 14, pp. 6867–6872, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. H. Watanabe, M. Ono, R. Ikeoka, M. Haratake, H. Saji, and M. Nakayama, “Synthesis and biological evaluation of radioiodinated 2,5-diphenyl-1,3,4-oxadiazoles for detecting β-amyloid plaques in the brain,” Bioorganic and Medicinal Chemistry, vol. 17, no. 17, pp. 6402–6406, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. H. Han, C. G. Cho, and P. T. Lansbury Jr., “Technetium complexes for the quantitation of brain amyloid,” Journal of the American Chemical Society, vol. 118, no. 18, pp. 4506–4507, 1996. View at Publisher · View at Google Scholar · View at Scopus
  51. N. A. Dezutter, R. J. Dom, T. J. De Groot, G. M. Bormans, and A. M. Verbruggen, “T99mc-MAMA-chrysamine G, a probe for beta-amyloid protein of Alzheimer's disease,” European Journal of Nuclear Medicine, vol. 26, no. 11, pp. 1392–1399, 1999. View at Publisher · View at Google Scholar · View at Scopus
  52. K. Serdons, T. Verduyckt, J. Cleynhens et al., “Synthesis and evaluation of a T99mc-BAT-phenylbenzothiazole conjugate as a potential in vivo tracer for visualization of amyloid β,” Bioorganic and Medicinal Chemistry Letters, vol. 17, no. 22, pp. 6086–6090, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. X. Chen, P. Yu, L. Zhang, and B. Liu, “Synthesis and biological evaluation of T99mc, Re-monoamine-monoamide conjugated to 2-(4-aminophenyl)benzothiazole as potential probes for β-amyloid plaques in the brain,” Bioorganic and Medicinal Chemistry Letters, vol. 18, no. 4, pp. 1442–1445, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. Z. P. Zhuang, M. P. Kung, C. Hou, K. Ploessl, and H. F. Kung, “Biphenyls labeled with technetium 99m for imaging β-amyloid plaques in the brain,” Nuclear Medicine and Biology, vol. 32, no. 2, pp. 171–184, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. K. S. Lin, M. L. Debnath, C. A. Mathis, and W. E. Klunk, “Synthesis and β-amyloid binding properties of rhenium 2-phenylbenzothiazoles,” Bioorganic and Medicinal Chemistry Letters, vol. 19, no. 8, pp. 2258–2262, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Oya, K. Plössl, M. P. Kung, D. A. Stevenson, and H. F. Kung, “Small and neutral TC(V)O BAT, bisaminoethanethiol (NS) complexes for developing new brain imaging agents,” Nuclear Medicine and Biology, vol. 25, no. 2, pp. 135–140, 1998. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Ono, R. Ikeoka, H. Watanabe et al., “Synthesis and evaluation of novel chalcone derivatives with T99mc/Re complexes as potential probes for detection of β-amyloid plaques,” ACS Chemical Neuroscience, vol. 1, no. 9, pp. 598–607, 2010. View at Publisher · View at Google Scholar